Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Activity of aztreonam in combination with novel β-lactamase inhibitors against metallo-β-lactamase-producing Enterobacterales from Spain.
Vázquez-Ucha JC, Alonso-Garcia I, Guijarro-Sánchez P, Lasarte-Monterrubio C, Álvarez-Fraga L, Cendón-Esteve A, Outeda M, Maceiras R, Peña-Escolano A, Martínez-Guitián M, Arca-Suárez J, Bou G, Beceiro A; GEMARA-SEIMC/REIPI Enterobacterales Study Group. Vázquez-Ucha JC, et al. Among authors: outeda m. Int J Antimicrob Agents. 2023 Apr;61(4):106738. doi: 10.1016/j.ijantimicag.2023.106738. Epub 2023 Feb 3. Int J Antimicrob Agents. 2023. PMID: 36736925
Antimicrobial Activity of Cefiderocol against the Carbapenemase-Producing Enterobacter cloacae Complex and Characterization of Reduced Susceptibility Associated with Metallo-β-Lactamase VIM-1.
Lasarte-Monterrubio C, Guijarro-Sánchez P, Vázquez-Ucha JC, Alonso-Garcia I, Alvarez-Fraga L, Outeda M, Martinez-Guitian M, Peña-Escolano A, Maceiras R, Lence E, González-Bello C, Arca-Suárez J, Bou G, Beceiro A. Lasarte-Monterrubio C, et al. Among authors: outeda m. Antimicrob Agents Chemother. 2023 May 17;67(5):e0150522. doi: 10.1128/aac.01505-22. Epub 2023 Apr 13. Antimicrob Agents Chemother. 2023. PMID: 37195077 Free PMC article.
Epidemiology, resistance genomics and susceptibility of Acinetobacter species: results from the 2020 Spanish nationwide surveillance study.
Lasarte-Monterrubio C, Guijarro-Sánchez P, Alonso-Garcia I, Outeda M, Maceiras R, González-Pinto L, Martínez-Guitián M, Fernández-Lozano C, Vázquez-Ucha JC, Bou G, Arca-Suárez J, Beceiro A. Lasarte-Monterrubio C, et al. Among authors: outeda m. Euro Surveill. 2024 Apr;29(15):2300352. doi: 10.2807/1560-7917.ES.2024.29.15.2300352. Euro Surveill. 2024. PMID: 38606569 Free PMC article.
Observational Study to Compare Biological Drug Concentration Quantification Techniques and Immunogenicity in Patients with Immune-Mediated Diseases.
Martínez-Pradeda A, Elberdín L, Porta-Sánchez Á, Outeda M, Diz-Lois Palomares MT, Vázquez-Rey T, González-Conde B, Estévez-Prieto E, Gómez-Besteiro MI, Martín-Herranz I. Martínez-Pradeda A, et al. Among authors: outeda m. Biomedicines. 2024 Apr 10;12(4):839. doi: 10.3390/biomedicines12040839. Biomedicines. 2024. PMID: 38672193 Free PMC article.
Novel Resistance Regions Carrying TnaphA6, blaVIM-2, and blaPER-1, Embedded in an ISPa40-Derived Transposon from Two Multi-Resistant Pseudomonas aeruginosa Clinical Isolates.
Papa-Ezdra R, Cordeiro NF, Outeda M, Garcia-Fulgueiras V, Araújo L, Seija V, Ayala JA, Bado I, Vignoli R. Papa-Ezdra R, et al. Among authors: outeda m. Antibiotics (Basel). 2023 Feb 2;12(2):304. doi: 10.3390/antibiotics12020304. Antibiotics (Basel). 2023. PMID: 36830215 Free PMC article.
Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago.
Elberdín L, Fernández-Torres RM, Paradela S, Mateos M, Blanco E, Balboa-Barreiro V, Gómez-Besteiro MI, Outeda M, Martín-Herranz I, Fonseca E. Elberdín L, et al. Among authors: outeda m. Dermatol Ther (Heidelb). 2022 Mar;12(3):761-770. doi: 10.1007/s13555-022-00693-2. Epub 2022 Feb 28. Dermatol Ther (Heidelb). 2022. PMID: 35226302 Free PMC article.
15 results